Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 1 2Phase 4 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4690INDUSTRY 2362NIH 888NETWORK 287FED 9UNKNOWN 4OTHER_GOV 4INDIV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Pain 1Neoplasms 1Colorectal Neoplasms 1Colitis, Ulcerative 1Breast Neoplasms 1

Interventions

nabiximols 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Has results × Clear all
NCT01520324 2019-02-08

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

CosmoTech

Phase 2 Completed
53 enrolled 13 charts

Colitis, Ulcerative

NCT02295774 2018-11-05

Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA

CosmoTech

Phase 2 Completed
10 enrolled 6 charts
Gastrointestinal

Colorectal Neoplasms

NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

ChineseAMS

Phase 2 Unknown
33 enrolled 5 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00530764 2013-06-20

SPRAY

GWPharm

Phase 2 Completed
360 enrolled 18 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡